Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Sep 14, 2009; 15(34): 4240-4262
Published online Sep 14, 2009. doi: 10.3748/wjg.15.4240
Table 1 Summary of the terms used singly or in combination for evidence acquisition
Primary MeSH termsSecondary MeSH terms (Epidemiology, diagnosis)Secondary MeSH terms (treatment, palliation)
Bile duct neoplasm(s)Differential diagnosisTreatment outcome(s)
Biliary tract neoplasm(s)Early diagnosisSurgery
Common bile duct neoplasm(s)Risk factor(s)Transplantation
Liver neoplasm(s)Diagnostic imagingBiliary tract
Bile duct(s)Magnetic resonance imagingSurgical procedures
Common bile ductEndosonographyLiver transplantation
Intrahepatic bile duct(s)UltrasonographyOrgan transplantation
Extrahepatic bile duct(s)Emission computed tomographyClinical trial
Biliary tract disease(s)Radionuclide imagingControlled clinical trial(s)
Bile duct disease(s)Positron emission tomographyRandomized controlled trial(s)
X-rayClinical trial (phase I)
Computed tomographyClinical trial (phase II)
Biopsy (needle)Clinical trial (phase III)
Biopsy (fine needle)Clinical trial (phase IV)
CytologyDrug therapy
Tumor markers (biological) antigen(s)Adjuvant
Carcinoembryonic antigenAntineoplastic agent(s)
Ca 19-9 antigenCombined modality therapy
Ca 125 antigenAntineoplastic
Endoscopic retrograde cholangiopancreatographyCombined chemotherapy protocols
CholangiographyNeoadjuvant therapy
In situ hybridizationRadiotherapy
Fluorescence in situ hybridizationAdjuvant embolization
Nucleic acid hybridizationPortal vein embolization
Computed assisted image processingDrainage
Obstructive jaundice